Pharmacogenetic determinants for discontinuation of non-ergo…
Pharmacogenetic determinants for discontinuation of non-ergoline dopamine agonists in Parkinson%27s disease.
Article, Chapter
Full text availability for this item
Coverage:
- 1999~present; volume:14~present;issue:1~present
Coverage:
- 1996-01-01~present; volume:11~present;issue:1~present